By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    improving patient experience
    6 Ways to Improve Patient Satisfaction Within Hospitals
    December 1, 2021
    degree for healthcare job
    What Are The Health Benefits Of Having A Degree?
    March 9, 2022
    custom software development is changing healthcare
    Digital Customer Journey Mapping and its Importance for Healthcare
    July 21, 2022
    Latest News
    Grounded Healing: A Natural Ally for Sustainable Healthcare Systems
    May 16, 2025
    Learn how to Renew your Medical Card in West Virginia
    May 16, 2025
    Choosing the Right Supplement Manufacturer for Your Brand
    May 1, 2025
    Engineering Temporary Hospitals for Extreme Weather
    April 24, 2025
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    Can Thinking Younger Make You Live Longer?
    April 20, 2011
    Image
    Obesity’s Outlook Unchanged
    June 13, 2011
    When It’s An Emergency Elderly Not Treated As Well in Hospitals
    July 16, 2011
    Latest News
    Building Smarter Care Teams: Aligning Roles, Structure, and Clinical Expertise
    May 18, 2025
    The Critical Role of Healthcare in Personal Injury Recovery: A Comprehensive Guide for Victims
    May 14, 2025
    The Backbone of Successful Trials: Clinical Data Management
    April 28, 2025
    Advancing Your Healthcare Career through Education and Specialization
    April 16, 2025
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Obesity’s Outlook Unchanged
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > Public Health > Obesity’s Outlook Unchanged
Public HealthTechnology

Obesity’s Outlook Unchanged

PatrickDriscoll
Last updated: June 13, 2011 2:43 pm
PatrickDriscoll
Share
3 Min Read
Image
SHARE

Drugs for the clinical treatment of obesity have taken hits over the past year.  Denied regulatory approvals, market withdrawals and the resulting industry moves, if projected going forward, leave an overall negative impression of the market.  However, describing the “current” market for obesity drugs based on the “past as prologue” would be an incomplete picture.

Drugs for the clinical treatment of obesity have taken hits over the past year.  Denied regulatory approvals, market withdrawals and the resulting industry moves, if projected going forward, leave an overall negative impression of the market.  However, describing the “current” market for obesity drugs based on the “past as prologue” would be an incomplete picture.  Certainly, the attitude of the FDA in rejecting Arena’s Lorcaserin and Orexigen’s Contrave, as well the withdrawal by Abbott of Meridia and similar developments have tempered the “optimism” of obesity drug developers.  But optimism remains, stemming from an overwhelming need and therefore opportunity for obesity drugs.  

 

More Read

Diabetes on the Rise Among Young People
Health Care Buzz Today
Empower Patients and Consumers with Information Technologies
Personalized Prevention, Part II – The Psychology of Engagement
Top 10 iPhone Apps that Doctors and Medical Students Can Rely On

Source: “Products, Technologies and Markets Worldwide for the Clinical Management of Obesity, 2011-2019.” Report #S835 (copyright 2011, MedMarket Diligence, LLC).

Simultaneously, medical device development — restrictive devices, artificial fullness, malabsorption, gastric emptying, and appetite suppression devices — continue to see strong growth (i.e., double-digit CAGR) as approved devices see expanded indications (e.g., Lap Band) and new devices are steadily introduced to the market.

Surgical procedures and device implantation, however much they may avoid the challenges of drug complications (or just the FDA’s perceptions), are not free of challenges (including, of course, the need for surgery that is in many cases invasive), such as that there is a growing recognition that these are not permanent fixes and may require that expensive repeat procedures by done.

The short-term view of the obesity drug market is that it is “dead”, or at least on life support, but given the current market for obesity management products ($billions) and the indisputable accelerated growth in obesity prevalence and the recognition in the healthcare arena of obesity’s co-morbidity costs, one must conclude that the short-term view is not going to hold for very long at least not by many who are motivated by opportunity.

TAGGED:obesitypublic health
Share This Article
Facebook Copy Link Print
Share
By PatrickDriscoll
Follow:
I serve the interests of medical technology company decision-makers, venture-capitalists, and others with interests in medtech producing worldwide analyses of medical technology markets for my audience of mostly medical technology companies (but also rapidly growing audience of biotech, VC, and other healthcare decision-makers). I have a small staff and go to my industry insiders (or find new ones as needed) to produce detailed, reality-grounded analyses of current and potential markets and opportunities. I am principally interested in those core clinical applications served by medical devices, which are expanding to include biomaterials, drug-device hybrids and other non-device technologies either competing head-on with devices or being integrated with devices in product development. The effort and pain of making every analysis global in scope is rewarded by my audience's loyalty, since in the vast majority of cases they too have global scope in their businesses.Specialties: Business analysis through syndicated reports, and select custom engagements, on medical technology applications and markets in general/abdominal/thoracic surgery, interventional cardiology, cardiothoracic surgery, patient monitoring/management, wound management, cell therapy, tissue engineering, gene therapy, nanotechnology, and others.

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

Clinical Expertise
Building Smarter Care Teams: Aligning Roles, Structure, and Clinical Expertise
Health care
May 18, 2025
Grounded Healing: A Natural Ally for Sustainable Healthcare Systems
Grounded Healing: A Natural Ally for Sustainable Healthcare Systems
Health
May 15, 2025
Learn how to Renew your Medical Card in West Virginia
Learn how to Renew your Medical Card in West Virginia
Health
May 15, 2025
Dr. Klaus Rentrop Shares Acute Myocardial Infarction heart treatment
Dr. Klaus Rentrop Shares Acute Myocardial Infarction
Cardiology
May 13, 2025

You Might also Like

Cell-tissue-applications
BusinessMedical InnovationsTechnology

Applications, Global Markets in Tissue Engineering and Cell Therapy

April 21, 2014
medical devices
Technology

Post Market Surveillance for Medical Devices: Essential or Overreaching?

May 11, 2023
man-95720_640
eHealthHealth ReformMedical RecordsPolicy & LawTechnology

Time Thieves

April 15, 2014
electronic health records adoption
BusinesseHealthHospital AdministrationMedical RecordsTechnology

Is Meaningful Use Working? How Can Innovators Encourage EHR Adoption?

November 11, 2014
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?